Cell and Gene Therapy, Industry

NIH and FDA Lead Coalition to Accelerate Gene Therapy Development for Rare Diseases

October 29, 2021

Via: Biopharm International

The National Institutes of Health (NIH) announced the formation of the Bespoke Gene Therapy Consortium (BGTC) on Oct. 27th, 2021. In partnership with FDA, ten pharmaceutical companies, and five non-profits, this coalition is aimed at accelerating development of gene therapies […]